Valuation (2%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -410.15 | N/A |
| PEG Ratio (TTM) | -4.10 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 83.61 | N/A |
| P/FCF Ratio (TTM) | -2,353.63 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.44% | N/A |
| ROE (TTM) | -40.59% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 329.42% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | -56,289.32% | N/A | N/A |
| Cash Flow | -24,387.99% | N/A | N/A |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.81 | N/A |
| Quick Ratio (TTM) | 1.81 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 3.40 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |